Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-06 · accession 0001567619-21-013155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-08 | 2021-07-06 | IDYA | Throne Jason | SVP, GC | M - OptEx | $8.52 | +10.0K | 10.0K | New | +$85.2K |
| DM | 2021-07-08 | 2021-07-06 | IDYA | Throne Jason | SVP, GC | S - Sale+OE | $22.24 | -10.0K | 3,532 | -74% | -$222.4K |
| DM | 2021-07-08 | 2021-07-06 | IDYA | Throne Jason | SVP, GC | M - OptEx | $0.00 | -10.0K | 67.4K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | M | A | 7,610 | $7.01 | 7,610 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-06 | M | A | 2,390 | $13.34 | 10,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-06 | S | D | 359 | $22.68 | 0 | D | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $22.57 to $22.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2021-07-06 | S | D | 1,142 | $22.68 | 2,390 | D | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $22.57 to $22.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2021-07-06 | S | D | 2,031 | $22.16 | 359 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $21.56 to $22.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2021-07-06 | S | D | 6,468 | $22.16 | 3,532 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $21.56 to $22.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-07-06 | M | D | 2,390 | $0.00 | 72,610 | D | $13.34 · — to 2030-06-30 | 2,390 Common Stock | (F5) 25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 8 | Derivative | Stock Option (right to buy) | 2021-07-06 | M | D | 7,610 | $0.00 | 67,390 | D | $7.01 · — to 2029-10-08 | 7,610 Common Stock | (F4) 25% of the shares subject to the option vest on the first anniversary measured from October 9, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |